EFAVIRENZ TABLET FORMULATION HAVING UNIQUE BIOPHARMACEUTICAL CHARACTERISTICS
摘要
The present invention provides an efavirenz tablet formulation which, when administered as a single dose to a subject, provides a mean maximum plasma concentration (Cmax) of about 4µM to about 14µM, a mean time of maximum plasma concentration (Tmax) of about 2 hours to about 5 hours, and a mean area under the plasma concentration versus time curve from time zero to time infinity (AUC) of about 190µM/hour to about 470µM/hour.
申请公布号
WO03045327(A3)
申请公布日期
2003.11.13
申请号
WO2002US38118
申请日期
2002.11.26
申请人
BRISTOL-MYERS SQUIBB COMPANY;HUSSAIN, MUNIR, A.;GAO, JULIA, ZH.;MOTHERAM, RAJESHWAR;GRAY, DAVID, B.
发明人
HUSSAIN, MUNIR, A.;GAO, JULIA, ZH.;MOTHERAM, RAJESHWAR;GRAY, DAVID, B.